首页> 外文期刊>Human Genetics >Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene
【24h】

Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene

机译:4号染色体的缺失与宫颈癌的发展有差异:slit2作为候选抑癌基因的证据

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this study was to locate the candidate tumor suppressor genes (TSGs) loci in the chromosomal 4p15-16, 4q22-23 and 4q34-35 regions associated with the development of uterine cervical carcinoma (CA-CX). Deletion mapping of the regions by microsatellite markers identified six discrete areas with high frequency of deletions, viz. 4p16.2 (D1: 40%), 4p15.31 (D2: 35–38%), 4p15.2 (D3: 37–40%), 4q22.2 (D4: 34%), 4q34.2-34.3 (D5: 37–59%) and 4q35.1 (D6: 40–50%). Significant correlation was noted among the deleted regions D1, D2 and D3. The deletions in D1, D2, D5 and D6 regions are suggested to be associated with the cervical intraepithelial neoplasia (CIN), and deletions in the D2, D3, D5 and D6 regions seems to be associated with progression of CA-CX. The deletions in the D2 and D6 regions showed significant prognostic implications (P = 0.001; 0.02). The expression of the candidate TSG SLIT2 mapped to D2 region gradually reduced from normal cervix uteri →CIN → CA-CX. SLIT2 promoter hypermethylation was seen in 28% CIN samples and significantly increased with tumor progression (P = 0.04). Significant correlation was seen between SLIT2 deletion and its promoter methylation (P = 0.001), indicating that both these phenomena could occur simultaneously to inactivate this gene. Immunohistochemical analysis showed reduced expression of SLIT2 in cervical lesions and CA-CX cell lines. Although no mutation was detected in the SLIT2 promoter region (?432 to + 55 bp), CC and AA haplotypes were seen in ?227 and ?195 positions, respectively. Thus, it indicates that inactivation of SLIT2-ROBO1 signaling pathway may have an important role in CA-CX development.
机译:这项研究的目的是在与宫颈癌(CA-CX)发生有关的染色体4p15-16、4q22-23和4q34-35区域定位候选肿瘤抑制基因(TSGs)基因座。通过微卫星标记对区域的缺失作图确定了具有高缺失频率的六个离散区域,即。 4p16.2(D1:40%),4p15.31(D2:35–38%),4p15.2(D3:37–40%),4q22.2(D4:34%),4q34.2-34.3( D5:37–59%)和4q35.1(D6:40–50%)。在删除的区域D1,D2和D3之间发现了显着的相关性。 D1,D2,D5和D6区的缺失被认为与宫颈上皮内瘤变(CIN)相关,而D2,D3,D5和D6区的缺失似乎与CA-CX的进展有关。 D2和D6区的缺失显示出明显的预后影响(P = 0.001; 0.02)。映射到D2区域的候选TSG SLIT2的表达从正常子宫颈→CIN→CA-CX逐渐降低。在28%的CIN样品中发现SLIT2启动子过度甲基化,并且随着肿瘤的进展而显着增加(P = 0.04)。 SLIT2缺失与其启动子甲基化之间存在显着相关性(P = 0.001),表明这两种现象可能同时发生以使该基因失活。免疫组织化学分析显示SLIT2在宫颈病变和CA-CX细胞系中的表达减少。尽管在SLIT2启动子区域(?432至+ 55 bp)未检测到突变,但分别在?227和?195位置看到了CC和AA单倍型。因此,这表明SLIT2-ROBO1信号通路的失活可能在CA-CX的发展中起重要作用。

著录项

  • 来源
    《Human Genetics》 |2007年第1期|71-81|共11页
  • 作者单位

    Department of Oncogene Regulation Chittaranjan National Cancer Institute 37 S.P. Mukherjee Road Kolkata 700026 India;

    Department of Oncogene Regulation Chittaranjan National Cancer Institute 37 S.P. Mukherjee Road Kolkata 700026 India;

    Department of Oncogene Regulation Chittaranjan National Cancer Institute 37 S.P. Mukherjee Road Kolkata 700026 India;

    Department of Gynaecology Oncology Chittaranjan National Cancer Institute 37 S.P. Mukherjee Road Kolkata 700026 India;

    Department of Gynaecology Oncology Chittaranjan National Cancer Institute 37 S.P. Mukherjee Road Kolkata 700026 India;

    Department of Pathology Medical College and Hospital Kolkata 700073 India;

    Human Genetics and Genomic Division Indian Institute of Chemical Biology Kolkata 700032 India;

    Department of Oncogene Regulation Chittaranjan National Cancer Institute 37 S.P. Mukherjee Road Kolkata 700026 India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 01:51:38

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号